Phibro Animal Health (NASDAQ:PAHC) Updates FY 2025 Earnings Guidance

Phibro Animal Health (NASDAQ:PAHC) updated its FY 2025 earnings guidance on Wednesday. The company provided earnings per share guidance of 1.220-1.370 for the period, compared to the consensus earnings per share estimate of 1.380. The company issued revenue guidance of $1.0 billion-$1.1 billion, compared to the consensus revenue estimate of $1.1 billion.

Analyst Upgrades and Downgrades

Several analysts have recently weighed in on the company. Barclays boosted their price target on Phibro Animal Health from $10.00 to $13.00 and gave the stock an underweight rating in a report on Friday, May 10th. Bank of America boosted their price target on Phibro Animal Health from $13.00 to $15.00 and gave the stock an underperform rating in a report on Friday. Three equities research analysts have rated the stock with a sell rating, one has given a hold rating and one has assigned a buy rating to the company’s stock. According to data from MarketBeat, Phibro Animal Health presently has a consensus rating of Hold and a consensus price target of $13.25.

Phibro Animal Health Stock Performance

Shares of PAHC stock opened at $21.47 on Friday. The business’s 50 day simple moving average is $18.18 and its 200 day simple moving average is $15.94. Phibro Animal Health has a one year low of $9.40 and a one year high of $21.83. The stock has a market capitalization of $869.60 million, a PE ratio of 67.09, a PEG ratio of 4.71 and a beta of 0.57. The company has a debt-to-equity ratio of 1.69, a current ratio of 3.16 and a quick ratio of 1.67.

Phibro Animal Health Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, September 25th. Investors of record on Wednesday, September 4th will be issued a $0.12 dividend. This represents a $0.48 annualized dividend and a yield of 2.24%. The ex-dividend date of this dividend is Wednesday, September 4th. Phibro Animal Health’s payout ratio is presently 150.00%.

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.